Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Depression is a leading cause of disability worldwide, affecting nearly 16% of the general population. Its physiopathology remains unclear. Based on gene-environment studies and epigenetic studies, a main hypothesis proposed that the major depressive episode (MDE) results from the convergence of multiple factors including biological factors such as multi-genic vulnerability, hormonal and immunological variations as well as environmental factors. As a consequence, mRNA could define a biological signature of the MDE.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| pan-genomic screen | Experimental | A pan-genomic screen by blood prelevement and psychometric data collection will be set-up on a subset of MDE and control samples to identify mRNA candidates for a transcriptional signature of MDE, |
|
| control | Sham Comparator | a pan genomic screening by blood prelevement and psychometric data collection wil be performed on healthy subject |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| blood prelevement | Other | blood sample will be done at the inclusion then at T 2 weeks, T8 weeks, T30weeks |
|
| Measure | Description | Time Frame |
|---|---|---|
| describe a transcriptional signature of the Major Depressive Episode. | The major aim of our study is to compare the expression level of selected genes between patient suffering from major depression and control subjects and within patients across the MDE evolution. We plan to describe a transcriptional signature of the MDE. | 6 months |
| Measure | Description | Time Frame |
|---|---|---|
| evaluate the role played by confounding factors as genetic polymorphisms, | evaluate the role played by confounding factors as genetic polymorphisms to distinguish bipolar from unipolar depression | 6 months |
| Measure | Description | Time Frame |
|---|---|---|
| evaluate the role played by confounding factors as immune phenotype | evaluate the role played by confounding factors as immune phenotype to distinguish bipolar from unipolar depression | 6 months |
| evaluate the role played by confounding factors as psychotropic medications |
Inclusion Criteria:
Major depressive disorder at inclusion according to the DSM IV at the time of the inclusion,
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| jean Naudin, MD | Assistance Publique Hopitaux De Marseille | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Assistance Publique Hopitaux de Marseille | Marseille | 13009 | France |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 32242018 | Derived | Belzeaux R, Gorgievski V, Fiori LM, Lopez JP, Grenier J, Lin R, Nagy C, Ibrahim EC, Gascon E, Courtet P, Richard-Devantoy S, Berlim M, Chachamovich E, Theroux JF, Dumas S, Giros B, Rotzinger S, Soares CN, Foster JA, Mechawar N, Tall GG, Tzavara ET, Kennedy SH, Turecki G. GPR56/ADGRG1 is associated with response to antidepressant treatment. Nat Commun. 2020 Apr 2;11(1):1635. doi: 10.1038/s41467-020-15423-5. |
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D003865 | Depressive Disorder, Major |
| ID | Term |
|---|---|
| D003866 | Depressive Disorder |
| D019964 | Mood Disorders |
| D001523 | Mental Disorders |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| psychometric data collection | Other |
|
|
evaluate the role played by confounding factors as psychotropic medications to distinguish bipolar from unipolar depression |
| 6 months |